Kindred Biosciences Inc. (KIN)

7.47
0.29 3.74
NASDAQ : Health Technology
Prev Close 7.76
Open 7.78
Day Low/High 7.30 / 7.89
52 Wk Low/High 5.96 / 15.11
Volume 107.39K
Avg Volume 175.80K
Exchange NASDAQ
Shares Outstanding 39.06M
Market Cap 293.74M
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Kindred Biosciences Secures $50 Million Debt Facility With Solar Capital Partners

Kindred Biosciences Secures $50 Million Debt Facility With Solar Capital Partners

SAN FRANCISCO, Oct. 2, 2019 /PRNewswire/ -- Kindred Biosciences, Inc.

Unibet Takes On Its Second U.S. Market

Unibet Takes On Its Second U.S. Market

VALLETTA, Malta, Sept. 27, 2019 /PRNewswire/ -- Kindred Group´s flagship brand Unibet takes on its second U.

Kindred Biosciences Awarded A Contract By The National Cancer Institute In Support Of The PREVENT Cancer Program

Kindred Biosciences Awarded A Contract By The National Cancer Institute In Support Of The PREVENT Cancer Program

SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- Kindred Biosciences, Inc.

Kindred Biosciences Announces Second Quarter 2019 Financial Results And Unveils Positive Results From Pilot Efficacy Study Of Parvovirus Monoclonal Antibody

Kindred Biosciences Announces Second Quarter 2019 Financial Results And Unveils Positive Results From Pilot Efficacy Study Of Parvovirus Monoclonal Antibody

- Mortality benefit seen in both prophylaxis and treatment of parvovirus infection

Kindred Biosciences Announces Positive Results From Pilot Field Effectiveness Study Of Its Interleukin-31 Monoclonal Antibody For The Treatment Of Atopic Dermatitis In Dogs

Kindred Biosciences Announces Positive Results From Pilot Field Effectiveness Study Of Its Interleukin-31 Monoclonal Antibody For The Treatment Of Atopic Dermatitis In Dogs

- Achieved rapid and dramatic reduction in pruritus (itch) and CADESI score versus placebo.

Relative Strength Alert For Kindred Biosciences

Relative Strength Alert For Kindred Biosciences

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Kindred Biosciences To Announce Second Quarter 2019 Financial Results

Kindred Biosciences To Announce Second Quarter 2019 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Thursday, August 1, 2019

A Handful of Small Biotechs That Make for Merger Chatter

A Handful of Small Biotechs That Make for Merger Chatter

The names include a veterinary drug concern plus companies with successful drugs on the market.

Kindred Biosciences To Participate In The B. Riley FBR Institutional Investor Conference, Stifel 2019 Dental & Veterinary Conference And 9th Annual LD Micro Invitational

Kindred Biosciences To Participate In The B. Riley FBR Institutional Investor Conference, Stifel 2019 Dental & Veterinary Conference And 9th Annual LD Micro Invitational

SAN FRANCISCO, May 13, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the B.

Kindred Biosciences Announces First Quarter 2019 Financial Results

Kindred Biosciences Announces First Quarter 2019 Financial Results

SAN FRANCISCO, May 9, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the first quarter ended March 31, 2019 and provided...

Kindred Biosciences To Announce First Quarter 2019 Financial Results

Kindred Biosciences To Announce First Quarter 2019 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, May 9, 2019

Kindred Biosciences Is Now Oversold (KIN)

Kindred Biosciences Is Now Oversold (KIN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Kindred Biosciences Becomes Oversold (KIN)

Kindred Biosciences Becomes Oversold (KIN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

KIN Makes Bullish Cross Above Critical Moving Average

KIN Makes Bullish Cross Above Critical Moving Average

In trading on Monday, shares of Kindred Biosciences Inc crossed above their 200 day moving average of $11.89, changing hands as high as $12.00 per share. Kindred Biosciences Inc shares are currently trading up about 3% on the day.

First Week Of November 16th Options Trading For Kindred Biosciences (KIN)

First Week Of November 16th Options Trading For Kindred Biosciences (KIN)

Investors in Kindred Biosciences Inc saw new options begin trading this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the KIN options chain for the new November 16th contracts and identified the following put contract of particular interest.

Kindred Biosciences Is Now Oversold (KIN)

Kindred Biosciences Is Now Oversold (KIN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Kindred Biosciences Reaches Analyst Target Price

Kindred Biosciences Reaches Analyst Target Price

In recent trading, shares of Kindred Biosciences Inc have crossed above the average analyst 12-month target price of $11.92, changing hands for $12.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

2 Animal Drugmakers Worth a Sniff

2 Animal Drugmakers Worth a Sniff

Aratana Therapeutics and Kindred Biosciences are promising drug developers in the pet space.

These Insiders Are Still Finding Some Good Value in the Stock Market

These Insiders Are Still Finding Some Good Value in the Stock Market

Look at what they are buying.

The Final Fine-Tuned Gad Value Investment Portfolio for 2017

The Final Fine-Tuned Gad Value Investment Portfolio for 2017

We've made a few tweaks due to price changes, while others were based on a last-minute assessment of better value.

The 2017 Gad Value Investment Fund, Part 2

The 2017 Gad Value Investment Fund, Part 2

The second half of our value-stocks portfolio for the New Year.

2 Bargains That Are Hiding in Plain Sight

2 Bargains That Are Hiding in Plain Sight

Kindred Biosciences and GM may be 'too cheap not to own.'

Winning Value Portfolio Is Set to Beat the Market

Winning Value Portfolio Is Set to Beat the Market

Even if the markets were to take a dive, the strength of our holdings will prevail.

Good Stocks Can Come in Small Packages

Good Stocks Can Come in Small Packages

These 3 names may not draw attention, but they can draw profits.

Value Portfolio Performs Well Amid Brexit Turmoil

A group of seven to 15 securities, if carefully selected, can provide all the diversification an investor needs.

It's Patient Capital's Time to Prosper

Brexit has caused active investors to flee and created an opportunity for those who are patient.

Portfolio Patience Is a Virtue

The energy rally is a good example.